**Author details**

Chittipolu Ajaykumar Vision College of Pharmaceutical Sciences and Research, Hyderabad, India

\*Address all correspondence to: ajay239172@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**181**

*Overview on the Side Effects of Doxorubicin DOI: http://dx.doi.org/10.5772/intechopen.94896*

[1] Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, et al. Doxorubicin: the good, the bad and the ugly effect. Current medicinal chemistry. 2009 Sep 1;**16**(25):3267-3285 of doxorubicin and its metabolic

1;**86**(4):438-449

[10] Maton A, Hopkins J, McLaughlin CW, Johnson S,

product on cardiac RyR2 and SERCA2A. Molecular Pharmacology. 2014 Oct

Warner MQ, LaHart D, et al. Human biology and health. Englewood Cliffs, New Jersey, US: Prentice Hall; 1993

[11] Shirani K, Yousefsani BS, Shirani M, Karimi G. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A review. Phytotherapy Research. 2020 Feb;**17**

[12] Zhao X, Jin Y, Li L, Xu L, Tang Z, Qi Y, et al. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1. Pharmacological Research.

[13] Yang XL, Fan CH, Zhu HS. Photoinduced cytotoxicity of malonic acid [C60] fullerene derivatives and its mechanism. Toxicology in vitro. 2002

Tseng W, Li X, Mann J. Human carbonyl

[15] Gavelová M, Hladíková J, Vildová L, Novotná R, Vondráček J, Krčmář P, et al. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells. Chemico-biological interactions. 2008

[16] Ahmed OM, Abdul-Hamid MM, El-Bakry AM, Mohamed HM, Abdel Rahman ES. Camellia sinensis and epicatechin abate doxorubicin-induced hepatotoxicity in male Wistar rats via

2019 Aug 1;**146**:104276

Feb 1;**16**(1):41-46

[14] Forrest GL, Gonzalez B,

Sep 15;**60**(18):5158-5164

Oct 22;**176**(1):9-18

reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice. Cancer research. 2000

[2] Wani SH. Lone SA. Cancer: Diseases. Educreation Publishing; 2018 Nov 10

[3] Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M. Pharmacokineticpharmacodynamic relationships of the anthracycline anticancer drugs. Clinical Pharmacokinetics. 2002 May

[4] Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M. Pharmacokineticpharmacodynamic relationships of the anthracycline anticancer drugs. Clinical Pharmacokinetics. 2002 May

superoxide and hydrogen peroxide. Free Radical Biology and Medicine. 2010 Sep

Tao R, Honbo N, Karliner JS. Vincristine attenuates doxorubicin cardiotoxicity.

[7] Available from: http://chemocare. com/chemotherapy/drug-info/ doxorubicin.aspx [accessed on

Elmaaboud MA. Doxorubicin: Insights into Dynamics, Clinical Uses and Adverse Effects. J. Cancer Res.

Dulhunty AF, Beard NA. Adverse effects

1;**41**(6):431-444

**References**

1;**41**(6):431-444

15;**49**(6):919-962

5;**373**(4):555-560

2020-10-11].

2019;**7**:17-20

[5] Song Y, Buettner GR. Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form

[6] Chatterjee K, Zhang J,

Biochemical and biophysical research communications. 2008 Sep

[8] Alghorabi AA, Kabel AM,

[9] Hanna AD, Lam A, Tham S,

*Overview on the Side Effects of Doxorubicin DOI: http://dx.doi.org/10.5772/intechopen.94896*
